Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clynes

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Anticancer Research|May 22, 2004
Two-deoxyglucose as an anti-metabolite in human carcinoma cell line RPMI-2650 and drug-resistant variantsJ Keenan, Y Liang, M Clynes
Biochemical Society Transactions|January 1, 1976
Altered pyrimidine-salvage metabolism in a 5-fluorouracil-resistant mutant of Drosophila melanogasterM M Clynes, E J Duke
Cytotechnology|February 24, 2012
Separation of growth-stimulating activity of BSA fraction V from the bulk of albumin using Heparin Sepharose ChromatographyJ Keenan, G Doherty, M Clynes
Anticancer Research|June 28, 2007
Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinomaL Murphy, M Clynes, J Keenan
Transplantation Proceedings|June 15, 2004
Mechanisms associated with loss of glucose responsiveness in beta cellsL O'Driscoll, P Gammell, M Clynes
Biochemical Society Transactions|February 1, 1992
Analysis of the mechanism of resistance of 7 novel MDR variantsA Redmond, E Moran, M Clynes
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Multiple drug resistance in the human ovarian carcinoma cell line OAW42-AA Redmond, E Moran, M Clynes
Cytotechnology|January 1, 1993
Human cell lines as models for multidrug resistance in solid tumoursM Clynes, M Heenan, K Hall
Transplantation Proceedings|June 15, 2004
Expression in murine teratocarcinoma F9 cells of transcription factors involved in pancreas developmentL O'Driscoll, P Gammell, M Clynes
Current Cancer Drug Targets|April 8, 2003
Survivin: role in normal cells and in pathological conditionsL O'Driscoll, R Linehan, M Clynes
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Anticancer Research|May 22, 2004
Two-deoxyglucose as an anti-metabolite in human carcinoma cell line RPMI-2650 and drug-resistant variantsJ Keenan, Y Liang, M Clynes
Biochemical Society Transactions|January 1, 1976
Altered pyrimidine-salvage metabolism in a 5-fluorouracil-resistant mutant of Drosophila melanogasterM M Clynes, E J Duke
Cytotechnology|February 24, 2012
Separation of growth-stimulating activity of BSA fraction V from the bulk of albumin using Heparin Sepharose ChromatographyJ Keenan, G Doherty, M Clynes
Anticancer Research|June 28, 2007
Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinomaL Murphy, M Clynes, J Keenan
Transplantation Proceedings|June 15, 2004
Mechanisms associated with loss of glucose responsiveness in beta cellsL O'Driscoll, P Gammell, M Clynes
Biochemical Society Transactions|February 1, 1992
Analysis of the mechanism of resistance of 7 novel MDR variantsA Redmond, E Moran, M Clynes
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Multiple drug resistance in the human ovarian carcinoma cell line OAW42-AA Redmond, E Moran, M Clynes
Cytotechnology|January 1, 1993
Human cell lines as models for multidrug resistance in solid tumoursM Clynes, M Heenan, K Hall
Transplantation Proceedings|June 15, 2004
Expression in murine teratocarcinoma F9 cells of transcription factors involved in pancreas developmentL O'Driscoll, P Gammell, M Clynes
Current Cancer Drug Targets|April 8, 2003
Survivin: role in normal cells and in pathological conditionsL O'Driscoll, R Linehan, M Clynes
Pageof 10